Deras v. Johnson & Johnson

Plain English (For Everyone)

A woman sued Johnson & Johnson, claiming their talc powder caused her cancer. However, the court decided she didn't provide enough scientific proof that the product was the actual cause. Without this strong evidence, the company won the case because the court couldn't find a real dispute about whether the product was responsible.

For Legal Practitioners

The Fifth Circuit affirmed summary judgment, emphasizing the critical role of reliable expert testimony under Daubert. The plaintiff's failure to establish the admissibility of her causation experts meant she could not create a genuine dispute of material fact, leading to judgment as a matter of law for the defendant. This reinforces the need for robust scientific evidence and proper expert qualification in product liability cases.

For Law Students

This case tests the admissibility of expert testimony in product liability litigation, specifically under the Daubert standard. The Fifth Circuit's decision highlights how unreliable or unqualified expert opinions can prevent a plaintiff from establishing causation, thereby failing to survive summary judgment. Students should focus on the application of Daubert and its impact on proving causation in toxic tort cases.

Newsroom Summary

The Fifth Circuit ruled against a woman suing Johnson & Johnson over cancer claims linked to talc products. The court found her scientific evidence insufficient to prove the product caused her illness, upholding a lower court's decision that favored the company.

Constitutional Issues

Whether the arbitration clauses are unconscionable and therefore unenforceable under the Federal Arbitration Act.Whether the district court erred in denying the motion to compel arbitration.

Rule Statements

"The FAA reflects a liberal federal policy favoring arbitration agreements, notwithstanding any contrary federal or state laws."

"To establish unconscionability, a party must show both procedural and substantive unconscionability, and both must be present to an adequate degree."

Remedies

Reversal of the district court's order denying the motion to compel arbitration.Remand to the district court with instructions to compel arbitration.

Scenario: You believe a product you used caused a serious illness, like cancer.

Your Rights: You have the right to sue a company if you believe their product directly caused your harm. However, you must be able to provide sufficient scientific evidence to prove that the product was the cause.

What To Do: Gather all evidence related to your product use and your illness. Consult with a lawyer specializing in product liability and toxic torts who can help you find qualified scientific experts to support your claim.

Is it legal for companies to sell talc-based products if they might be linked to cancer?

It depends. Companies can generally sell products unless there's a proven, direct causal link between the product and a specific harm that they failed to warn about or prevent. Courts will assess the scientific evidence presented to determine if such a link exists and if the company acted improperly.

This ruling applies to federal courts within the Fifth Circuit's jurisdiction (Louisiana, Mississippi, and Texas) but the principles of Daubert apply nationwide in federal courts.

For Plaintiffs in product liability lawsuits

This ruling underscores the heightened burden of proof for plaintiffs, particularly in establishing causation through expert testimony. Future plaintiffs must ensure their experts meet stringent admissibility standards like Daubert, or risk summary judgment.

For Product manufacturers

This decision offers reassurance to manufacturers facing product liability claims, especially those involving complex scientific causation. It highlights the importance of rigorous scientific defense and challenging the admissibility of opposing expert testimony.

Q: What is Deras v. Johnson & Johnson about?

Deras v. Johnson & Johnson is a case decided by Fifth Circuit on March 10, 2026. It involves Private Civil Federal.

Q: What court decided Deras v. Johnson & Johnson?

Deras v. Johnson & Johnson was decided by the Fifth Circuit, which is part of the federal judiciary. This is a federal appellate court.

Q: When was Deras v. Johnson & Johnson decided?

Deras v. Johnson & Johnson was decided on March 10, 2026.

Q: What is the citation for Deras v. Johnson & Johnson?

The citation for Deras v. Johnson & Johnson is . Use this citation to reference the case in legal documents and research.

Q: What type of case is Deras v. Johnson & Johnson?

Deras v. Johnson & Johnson is classified as a "Private Civil Federal" case. This describes the nature of the legal dispute at issue.

Q: What is the full case name and citation for the Fifth Circuit's decision regarding Johnson & Johnson's talc products?

The case is styled Deras v. Johnson & Johnson, and it was decided by the United States Court of Appeals for the Fifth Circuit. The specific citation would be found in the official reporters, but the decision addresses the admissibility of expert testimony in product liability claims.

Q: Who were the main parties involved in the Deras v. Johnson & Johnson lawsuit?

The main parties were the plaintiff, Ms. Deras, who alleged that Johnson & Johnson's talc-based products caused her ovarian cancer, and the defendant, Johnson & Johnson, the manufacturer of those products.

Q: What was the core dispute in the Deras v. Johnson & Johnson case?

The central dispute revolved around whether Ms. Deras could provide sufficient evidence, particularly through expert testimony, to prove that Johnson & Johnson's talc-based products were a cause of her ovarian cancer, a claim brought under product liability law.

Q: Which court issued the final decision in Deras v. Johnson & Johnson?

The United States Court of Appeals for the Fifth Circuit issued the final decision, affirming the lower court's ruling. This means the case was heard on appeal from a federal district court.

Q: When was the Fifth Circuit's decision in Deras v. Johnson & Johnson issued?

While the exact date of the Fifth Circuit's opinion is not provided in the summary, it was issued after the district court granted summary judgment to Johnson & Johnson, indicating a decision likely within the last few years.

Q: What was the outcome of the Deras v. Johnson & Johnson case at the Fifth Circuit?

The Fifth Circuit affirmed the district court's decision, meaning they agreed with the lower court's ruling. This resulted in a grant of summary judgment in favor of Johnson & Johnson, dismissing the plaintiff's case.

Q: Is Deras v. Johnson & Johnson published?

Deras v. Johnson & Johnson is a published, precedential opinion. Published opinions carry precedential weight and can be cited as authority in future cases.

Q: What was the ruling in Deras v. Johnson & Johnson?

The court ruled in favor of the defendant in Deras v. Johnson & Johnson. Key holdings: The court affirmed the grant of summary judgment because the plaintiff failed to present admissible expert testimony establishing a causal link between Johnson & Johnson's talc products and her ovarian cancer.; The plaintiff's expert testimony on general causation was deemed unreliable under the Daubert standard, as it failed to adequately demonstrate a scientifically valid methodology connecting talc exposure to ovarian cancer.; The court found that the plaintiff's specific causation evidence was also insufficient, relying on flawed epidemiological studies and failing to rule out other potential causes of her cancer.; Because the plaintiff could not establish causation, a necessary element of her product liability claims, the defendant was entitled to judgment as a matter of law.; The Fifth Circuit applied the Daubert standard to assess the admissibility of the plaintiff's scientific evidence, emphasizing the need for reliable methodology and scientifically sound conclusions..

Q: Why is Deras v. Johnson & Johnson important?

Deras v. Johnson & Johnson has an impact score of 65/100, indicating significant legal impact. This decision reinforces the stringent gatekeeping role of federal courts under the Daubert standard in toxic tort litigation, particularly in cases involving complex scientific causation. It highlights the difficulty plaintiffs face in proving causation in talc-ovarian cancer litigation without robust, admissible expert testimony, potentially impacting future claims against talc manufacturers.

Q: What precedent does Deras v. Johnson & Johnson set?

Deras v. Johnson & Johnson established the following key holdings: (1) The court affirmed the grant of summary judgment because the plaintiff failed to present admissible expert testimony establishing a causal link between Johnson & Johnson's talc products and her ovarian cancer. (2) The plaintiff's expert testimony on general causation was deemed unreliable under the Daubert standard, as it failed to adequately demonstrate a scientifically valid methodology connecting talc exposure to ovarian cancer. (3) The court found that the plaintiff's specific causation evidence was also insufficient, relying on flawed epidemiological studies and failing to rule out other potential causes of her cancer. (4) Because the plaintiff could not establish causation, a necessary element of her product liability claims, the defendant was entitled to judgment as a matter of law. (5) The Fifth Circuit applied the Daubert standard to assess the admissibility of the plaintiff's scientific evidence, emphasizing the need for reliable methodology and scientifically sound conclusions.

Q: What are the key holdings in Deras v. Johnson & Johnson?

1. The court affirmed the grant of summary judgment because the plaintiff failed to present admissible expert testimony establishing a causal link between Johnson & Johnson's talc products and her ovarian cancer. 2. The plaintiff's expert testimony on general causation was deemed unreliable under the Daubert standard, as it failed to adequately demonstrate a scientifically valid methodology connecting talc exposure to ovarian cancer. 3. The court found that the plaintiff's specific causation evidence was also insufficient, relying on flawed epidemiological studies and failing to rule out other potential causes of her cancer. 4. Because the plaintiff could not establish causation, a necessary element of her product liability claims, the defendant was entitled to judgment as a matter of law. 5. The Fifth Circuit applied the Daubert standard to assess the admissibility of the plaintiff's scientific evidence, emphasizing the need for reliable methodology and scientifically sound conclusions.

Q: What cases are related to Deras v. Johnson & Johnson?

Precedent cases cited or related to Deras v. Johnson & Johnson: Daubert v. Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993); Burden v. Ford Motor Co., 793 F.3d 512 (5th Cir. 2015).

Q: What legal standard did the Fifth Circuit apply when reviewing the expert testimony in Deras v. Johnson & Johnson?

The Fifth Circuit applied the Daubert standard to assess the reliability and admissibility of the plaintiff's expert testimony. This standard requires that expert testimony be based on scientific knowledge and be relevant to the facts of the case.

Q: Why did the Fifth Circuit find the plaintiff's expert testimony unreliable in Deras v. Johnson & Johnson?

The court found the expert testimony unreliable because it did not meet the Daubert standard. This implies the testimony may have lacked a sound scientific basis, methodological rigor, or a clear connection to the specific facts of Ms. Deras's case and the alleged causation.

Q: What is 'summary judgment' and why was it granted to Johnson & Johnson in Deras v. Johnson & Johnson?

Summary judgment is a ruling by a court that resolves a lawsuit without a full trial. It is granted when there is no genuine dispute of material fact and the moving party is entitled to judgment as a matter of law. Here, it was granted because the plaintiff lacked sufficient evidence of causation.

Q: What does it mean for the plaintiff to fail to present 'sufficient evidence' of causation in Deras v. Johnson & Johnson?

Failing to present sufficient evidence of causation means the plaintiff did not offer enough credible proof, particularly through admissible expert testimony, to demonstrate that Johnson & Johnson's talc products were a cause of her ovarian cancer. This falls short of the burden of proof required in a product liability claim.

Q: What is the 'Daubert standard' and how does it impact product liability cases like Deras v. Johnson & Johnson?

The Daubert standard governs the admissibility of expert testimony in federal courts. It requires judges to act as gatekeepers, ensuring that expert opinions are both reliable and relevant, preventing unreliable or speculative testimony from reaching the jury and potentially influencing their verdict.

Q: What is the 'burden of proof' in a product liability case like Deras v. Johnson & Johnson?

In a product liability case, the plaintiff bears the burden of proving that the product was defective and that this defect caused their injury. In Deras v. Johnson & Johnson, the plaintiff had to prove that the talc product caused her ovarian cancer, a burden she failed to meet.

Q: What does 'judgment as a matter of law' mean in the context of Deras v. Johnson & Johnson?

Judgment as a matter of law means the court decided the case based on the legal sufficiency of the evidence presented, rather than sending it to a jury for deliberation. In this instance, the court determined that, even viewing the evidence favorably to the plaintiff, no reasonable jury could find for her due to the lack of reliable causation evidence.

Q: Did the Fifth Circuit rule on the general safety of Johnson & Johnson's talc products in Deras v. Johnson & Johnson?

No, the Fifth Circuit's decision in Deras v. Johnson & Johnson did not rule on the general safety of the talc products. The ruling was specific to the plaintiff's failure to present sufficient evidence linking the product to her individual cancer diagnosis under the relevant legal standards.

Q: How does Deras v. Johnson & Johnson affect me?

This decision reinforces the stringent gatekeeping role of federal courts under the Daubert standard in toxic tort litigation, particularly in cases involving complex scientific causation. It highlights the difficulty plaintiffs face in proving causation in talc-ovarian cancer litigation without robust, admissible expert testimony, potentially impacting future claims against talc manufacturers. As a decision from a federal appellate court, its reach is national. This case is moderate in legal complexity to understand.

Q: What are the real-world implications of the Deras v. Johnson & Johnson ruling for consumers?

For consumers, this ruling reinforces the legal requirement to provide strong scientific evidence linking a product to an alleged harm. It means that claims of injury from consumer products, like talc, must be supported by reliable expert testimony that can withstand judicial scrutiny under standards like Daubert.

Q: How might the Deras v. Johnson & Johnson decision affect other lawsuits against Johnson & Johnson regarding talc products?

This decision could have a significant impact on other similar lawsuits. By affirming the exclusion of certain types of expert testimony, it may make it more difficult for other plaintiffs to establish causation and survive summary judgment motions in cases involving Johnson & Johnson's talc products.

Q: What does the Deras v. Johnson & Johnson ruling mean for manufacturers of consumer products?

Manufacturers can take some comfort in this ruling, as it highlights the importance of rigorous scientific evidence in defending against product liability claims. It underscores that plaintiffs must meet strict admissibility standards for expert testimony to proceed to trial.

Q: What are the potential compliance implications for companies following the Deras v. Johnson & Johnson decision?

Companies should ensure their product safety data and any scientific studies supporting their product's safety are robust and defensible. They should also be prepared to challenge expert testimony that does not meet the Daubert standard, as demonstrated by Johnson & Johnson's successful defense.

Q: Does the Deras v. Johnson & Johnson ruling mean talc is safe for use?

The ruling does not definitively declare talc safe. It specifically found that *this plaintiff* failed to present sufficient admissible evidence to prove *her* ovarian cancer was caused by Johnson & Johnson's talc products. Other cases or different evidence could lead to different conclusions.

Q: How does the Deras v. Johnson & Johnson decision fit into the broader legal history of talc litigation?

This case is part of a wave of litigation alleging that talcum powder causes cancer. While many cases have settled or been dismissed, decisions like Deras v. Johnson & Johnson, which focus on evidentiary standards, shape how these claims are litigated and the types of evidence required to succeed.

Q: What legal doctrines or precedents might have influenced the Fifth Circuit's decision in Deras v. Johnson & Johnson?

The decision is heavily influenced by the Supreme Court's ruling in Daubert v. Merrell Dow Pharmaceuticals, Inc., which established the standard for admitting scientific expert testimony. Precedent from the Fifth Circuit itself on product liability and summary judgment would also be critical.

Q: How does the Deras v. Johnson & Johnson ruling compare to other major product liability cases involving alleged carcinogens?

Similar to cases involving asbestos or Roundup, the core issue often revolves around proving causation. However, the specific focus on the Daubert standard's application to epidemiological and toxicological studies in Deras v. Johnson & Johnson highlights the critical gatekeeping role of judges in filtering scientific evidence.

Q: What was the docket number in Deras v. Johnson & Johnson?

The docket number for Deras v. Johnson & Johnson is 25-10977. This identifier is used to track the case through the court system.

Q: Can Deras v. Johnson & Johnson be appealed?

Potentially — decisions from federal appellate courts can be appealed to the Supreme Court of the United States via a petition for certiorari, though the Court accepts very few cases.

Q: How did the Deras v. Johnson & Johnson case reach the Fifth Circuit Court of Appeals?

The case reached the Fifth Circuit through an appeal of the district court's decision. After the district court granted summary judgment to Johnson & Johnson, Ms. Deras likely appealed, arguing that the district court erred in its legal conclusions or its application of the Daubert standard.

Q: What procedural step led to the final ruling in Deras v. Johnson & Johnson?

The procedural step that led to the final ruling was the district court's grant of summary judgment. This ruling was then reviewed and affirmed by the Fifth Circuit Court of Appeals, preventing the case from proceeding to a jury trial.

Q: What role did the district court play before the case reached the Fifth Circuit in Deras v. Johnson & Johnson?

The district court played a crucial role by initially hearing the case and presiding over discovery, including the critical phase of evaluating the admissibility of expert testimony. It was the district court that first granted summary judgment to Johnson & Johnson, finding the plaintiff's evidence insufficient.